Lack of "immunological fitness" during fasting in metabolically challenged animals

Journal of Lipid Research

Volumn 53, Issue 7, 2012, Pages 1254-1267

  Asterholm, Ingrid Wernstedt ^a   McDonald, John ^c   Blanchard, Pierre Gilles ^d   Sinha, Madhur ^c   Xiao, Qiang ^c   Mistry, Jehangir ^c   Rutkowski, Joseph M ^a   Deshaies, Yves ^d   Brekken, Rolf A ^a   Scherer, Philipp E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Millipore Corporation   (United States)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Acute phase reactants; Adipose tissue; Diabetes; Inflammation; Macrophages; Metabolic flexibility; Obesity; Vascular biology

Indexed keywords

ADIPONECTIN; ADIPSIN; ALPHA1 GLYCOPROTEIN; AMYLOID; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; VASCULOTROPIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CIRCULATION; CONTROLLED STUDY; DIET RESTRICTION; FAT INTAKE; FITNESS; FOOD DEPRIVATION; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOCHEMISTRY; IMMUNOLOGICAL FITNESS; INFLAMMATION; LIPID DIET; LIVER; MACROPHAGE ACTIVATION; METABOLIC REGULATION; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROVOCATION TEST;

AMYLOID; ANIMALS; BIOLOGICAL MARKERS; DIET, HIGH-FAT; FASTING; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; OROSOMUCOID;

EID: 84862330028     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M021725     Document Type: Article

References (38)

1. Sun, K., C. M. Kusminski, and P. E. Scherer. 2011. Adipose tissue remodeling and obesity. J. Clin. Invest. 121: 2094-2101.
2. Unger, R. H., and P. E. Scherer. 2010. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol. Metab. 21: 345-352.
3. Holland, W. L., and S. A. Summers. 2008. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr. Rev. 29: 381-402. (Pubitemid 351831506)
4. Holland, W. L., R. A. Miller, Z. V. Wang, K. Sun, B. M. Barth, H. H. Bui, K. E. Davis, B. T. Bikman, N. Halberg, J. M. Rutkowski, et al. 2011. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17: 55-63.
5. Holland, W. L., J. T. Brozinick, L. P. Wang, E. D. Hawkins, K. M. Sargent, Y. Liu, K. Narra, K. L. Hoehn, T. A. Knotts, A. Siesky, et al. 2007. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5: 167-179.
6. Samuel, V. T., K. F. Petersen, and G. I. Shulman. 2010. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 375: 2267-2277.
7. Holland, W. L., B. T. Bikman, L. P. Wang, G. Yuguang, K. M. Sargent, S. Bulchand, T. A. Knotts, G. Shui, D. J. Clegg, M. R. Wenk, et al. 2011. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121: 1858-1870.
8. Nduka, O. O., and J. E. Parrillo. 2009. The pathophysiology of septic shock. Crit. Care Clin. 25: 677-702.
9. Fahy, B. G., A. M. Sheehy, and D. B. Coursin. 2009. Glucose control in the intensive care unit. Crit. Care Med. 37: 1769-1776.
10. Kosteli, A., E. Sugaru, G. Haemmerle, J. F. Martin, J. Lei, R. Zechner, and A. W. Ferrante, Jr. 2010. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 120: 3466-3479.
11. Lin, Y., A. H. Berg, P. Iyengar, T. K. Lam, A. Giacca, T. P. Combs, M. W. Rajala, X. Du, B. Rollman, W. Li, et al. 2005. The hyperg-lycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 280: 4617-4626. (Pubitemid 40288630)
12. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science. 327: 656-661.
13. Combs, T. P., U. B. Pajvani, A. H. Berg, Y. Lin, L. A. Jelicks, M. Laplante, A. R. Nawrocki, M. W. Rajala, A. F. Parlow, L. Cheeseboro, et al. 2004. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 145: 367-383. (Pubitemid 38094532)
14. Nawrocki, A. R., M. W. Rajala, E. Tomas, U. B. Pajvani, A. K. Saha, M. E. Trumbauer, Z. Pang, A. S. Chen, N. B. Ruderman, H. Chen, et al. 2006. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281: 2654-2660. (Pubitemid 43845727)
15. Flier, J. S., K. S. Cook, P. Usher, and B. M. Spiegelman. 1987. Severely impaired adipsin expression in genetic and acquired obesity. Science. 237: 405-408.
16. Rosen, B. S., K. S. Cook, J. Yaglom, D. L. Groves, J. E. Volanakis, D. Damm, T. White, and B. M. Spiegelman. 1989. Adipsin and complement factor D activity: an immune-related defect in obesity. Science. 244: 1483-1487. (Pubitemid 19171684)
17. Kim, J. Y., E. van de Wall, M. Laplante, A. Azzara, M. E. Trujillo, S. M. Hofmann, T. Schraw, J. L. Durand, H. Li, G. Li, et al. 2007. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117: 2621-2637. (Pubitemid 47494363)
18. Asterholm, I. W., and P. E. Scherer. 2010. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am. J. Pathol. 176: 1364-1376.
19. Combs, T. P., J. A. Wagner, J. Berger, T. Doebber, W. J. Wang, B. B. Zhang, M. Tanen, A. H. Berg, S. O'Rahilly, D. B. Savage, et al. 2002. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology. 143: 998-1007. (Pubitemid 34164048)
20. Toseland, C. D., S. Campbell, I. Francis, P. J. Bugelski, and N. Mehdi. 2001. Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat. Diabetes Obes. Metab. 3: 163-170. (Pubitemid 32785325)
21. Guan, H. P., J. L. Goldstein, M. S. Brown, and G. Liang. 2009. Accelerated fatty acid oxidation in muscle averts fasting-induced hepatic steatosis in SJL/J mice. J. Biol. Chem. 284: 24644-24652.
22. Lin, Y., M. W. Rajala, J. P. Berger, D. E. Moller, N. Barzilai, and P. E. Scherer. 2001. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J. Biol. Chem. 276: 42077-42083.
23. Reigstad, C. S., G. O. Lunden, J. Felin, and F. Backhed. 2009. Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS ONE. 4: e5842.
24. Lovren, F., Y. Pan, A. Quan, P. E. Szmitko, K. K. Singh, P. C. Shukla, M. Gupta, L. Chan, M. Al-Omran, H. Teoh, et al. 2010. Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am. J. Physiol. Heart Circ. Physiol. 299: H656-H663.
25. Ohashi, K., J. L. Parker, N. Ouchi, A. Higuchi, J. A. Vita, N. Gokce, A. A. Pedersen, C. Kalthoff, S. Tullin, A. Sams, et al. 2010. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J. Biol. Chem. 285: 6153-6160.
26. Mandal, P., B. T. Pratt, M. Barnes, M. R. McMullen, and L. E. Nagy. 2011. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J. Biol. Chem. 286: 13460-13469.
27. Tateya, S., Y. Tamori, T. Kawaguchi, H. Kanda, and M. Kasuga. 2010. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology. 151: 971-979.
28. Kanda, H., S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, et al. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116: 1494-1505.
29. Uhlar, C. M., and A. S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. European J. Biochem. 265: 501-523. (Pubitemid 29488982)
30. Pajvani, U. B., M. E. Trujillo, T. P. Combs, P. Iyengar, L. Jelicks, K. A. Roth, R. N. Kitsis, and P. E. Scherer. 2005. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat. Med. 11: 797-803. (Pubitemid 41021214)
31. Grove, K. L., S. K. Fried, A. S. Greenberg, X. Q. Xiao, and D. J. Clegg. 2010. A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. Int. J. Obes. 34: 989-1000.
32. Poitou, C., A. Divoux, A. Faty, J. Tordjman, D. Hugol, A. Aissat, M. Keophiphath, C. Henegar, S. Commans, and K. Clement. 2009. Role of serum amyloid a in adipocyte-macrophage cross talk and adipocyte cholesterol efflux. J. Clin. Endocrinol. Metab. 94: 1810-1817.
33. Chiba, T., C. Y. Han, T. Vaisar, K. Shimokado, A. Kargi, M. H. Chen, S. Wang, T. O. McDonald, K. D. O'Brien, J. W. Heinecke, et al. 2009. Serum amyloid A3 does not contribute to circulating SAA levels. J. Lipid Res. 50: 1353-1362.
34. Meek, R. L., and E. P. Benditt. 1986. Amyloid A gene family expression in different mouse tissues. J. Exp. Med. 164: 2006-2017. (Pubitemid 17217979)
35. Cook, K. S., H. Y. Min, D. Johnson, R. J. Chaplinsky, J. S. Flier, C. R. Hunt, and B. M. Spiegelman. 1987. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science. 237: 402-405.
36. Kitagawa, K., B. S. Rosen, B. M. Spiegelman, G. E. Lienhard, and L. I. Tanner. 1989. Insulin stimulates the acute release of adipsin from 3T3-L1 adipocytes. Biochim. Biophys. Acta. 1014: 83-89. (Pubitemid 19261601)
37. Platt, K. A., H. Y. Min, S. R. Ross, and B. M. Spiegelman. 1989. Obesity-linked regulation of the adipsin gene promotor in transgenic mice. Proc. Natl. Acad. Sci. USA. 86: 7490-7494. (Pubitemid 19254482)
38. Cianflone, K., M. Maslowska, and A. D. Sniderman. 1999. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin. Cell Dev. Biol. 10: 31-41. (Pubitemid 129505536)